Starbucks, Elliot reportedly in settlement talks last week - Breaking The News
Download our appPlay StoreApp Store

Starbucks, Elliot reportedly in settlement talks last week

EPA-EFE/ADAM DAVIS

Elliott Management and Starbucks' board of directors engaged in settlement discussions last week to evaluate an activist proposal, according to CNBC's anonymous resources on Monday.

The meeting focused on reviewing the terms of the proposal put forward by Elliott, but as of now, no final decision has been made. The specific concerns the board has about the proposal remain undisclosed. Should the settlement talks reach a successful conclusion, Elliott managing partner Jesse Cohn might join Starbucks' board of directors, the media said.

In mid-July a report mentioned that Elliott Investment Management bought a substantial stake in Starbucks Corporation.

Related Stocks
Starbucks
Related News
Musk's xAI acquires social media platform X
Billionaire entrepreneur Elon Musk announced on Friday that X.AI Corp. (doing business as xAI) acquired the social media platform X in an all-stock transaction."xAI and X’s futures are intertwined. Today, we officially take the step to combine the data, models, compute, distribution and talent. This combination will unlock immense potential by blending xAI’s advanced AI capability and expertise with X’s massive reach. The combined company will...
Repsol UK to form new unit with NEO Energy
Spanish petrochemical company Repsol S.A. announced on Thursday that its British business will combine with NEO Energy Group's North Sea arm to form Neo Next Energy. The resulting unit will be managed by a joint team, with NEO owning 55% and Repsol 45%."This combination will create a jointly governed business which will call upon the key strengths of both shareholders," Repsol Exploration and Production Executive Managing Director Francisco Gea said....
Merck to buy Hengrui Pharma's drug for up to $1.8B
Merck & Co. Inc. said on Tuesday that it entered into an exclusive license agreement with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for a cardiovascular disease drug HRS-5346, currently in a phase 2 trial in China. Merck will pay $200 million upfront and commit to milestone payments of up to $1.8 billion, as well as royalties on net sales.The drug is an investigational oral small molecule inhibitor of lipoprotein(a) formation (lp(a)). "Elevated blood concentrations of...
Apollo takes 25% stake in BP Pipelines for $1B
BP plc announced on Friday that Apollo Funds will buy a non-controlling 25% stake in its pipelines business for around $1 billion. The transaction is expected to close in the second quarter of 2025. BP Pipelines owns a 12% interest in the Trans-Anatolian gas pipeline (TANAP), which carries natural gas from Azerbaijan across Turkey.BP said the funds will go toward its plan for $20 billion in divestment and other proceeds. "This [deal] unlocks capital from our...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.